BCLC STAGE B HEPATOCELLULAR CARCINOMA
Clinical trials for BCLC STAGE B HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BCLC STAGE B HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for BCLC STAGE B HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Tough-to-Treat liver cancer
Disease control CompletedThis study tested a combination of two drugs, futibatinib and pembrolizumab, in 14 adults with advanced or metastatic liver cancer that had not responded to prior treatment. The goal was to see if the combination could stop or slow cancer growth. The approach uses futibatinib to …
Matched conditions: BCLC STAGE B HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
AI scans 3000 liver cancer patients to pick best therapy
Knowledge-focused CompletedThis study analyzed medical images and data from 3000 patients with advanced liver cancer that cannot be removed by surgery. Researchers used an AI technique called radiomics to see if they could identify which patients would respond better to one of two standard treatments: TACE…
Matched conditions: BCLC STAGE B HEPATOCELLULAR CARCINOMA
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC